Delivery Order SPE2DB22D2206-SPE2DB25FEX96

Award Date 1/2/25
Potential Completion Date 1/24/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,200.50, is for the delivery of COMIRNATY 2024-25 (12 years and up) syringes of 0.3 mL. The contract has a firm fixed price pricing type and a completion date of November 14, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,220.84 firm fixed-price contract is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes (0.3 mL) to support military healthcare programs. The contract is not designated as a set-aside and has an ultimate completion date of January 22, 2025. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,220.84 firm fixed-price delivery order is for the supply of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 mL, with an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,961.16 firm fixed-price contract is for the delivery of COMIRNATY 2024-25(12Y UP) SYRG 0.3ML, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,467.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY 2024-25 syringes (0.3 ML) for individuals 12 years and older, with a completion date of November 12, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,402.80 firm fixed-price delivery order is for the supply of COMIRNATY 2024-25 (12Y UP) syringes (0.3 ML) and has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 16, 2024. The award, valued at $10,363.92, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes (0.3ML) and has an ultimate completion date of January 8, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $73,350 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The award is for the supply of COMIRNATY 2024-25 (12 years and up) syringes, 0.3 mL, with an ultimate completion date of September 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, under which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,961.16 firm fixed-price delivery order is for the supply of COMIRNATY 2024-25 (12Y UP) syringes (0.3ML) and has an ultimate completion date of December 16, 2024. This award is a standalone delivery order and is not associated with a larger contract vehicle. The contract does not have a set-aside designation,...
This federal contract award, valued at $5,134.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes in 0.3 ml doses. It is a firm-fixed-price delivery order that will be completed by November 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEX96
    Delivery Order

This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,220.84 firm fixed-price contract is for the delivery of COMIRNATY 2024-25 syringes for individuals aged 12 and up. The contract has an ultimate completion date of January 24, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/3/25, 11:12 AM